Results 181 to 190 of about 11,695,622 (343)

A Customizable Data Quality Tool for Global Observational Research Networks. [PDF]

Stud Health Technol Inform
Lewis J, Hogan B, Goss C, Rupasinghe D, Maruri F, Hamusonde K, Obregon S, Agarwal M, Jiamsakul A, Turner M, Katona A, Althoff K, Duda SN.   +12 more
europepmc   +1 more source

Water resources data for Ohio, water year 1974; Part 2, Water quality records [PDF]

, 1975
U.S. Geological Survey
openalex   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

EEG Data Quality in Large-Scale Field Studies in India and Tanzania. [PDF]

eNeuro
Vianney JM, Swaminathan S, Newson JJ, Parameshwaran D, Puthanmadam Subramaniyam N, Roy SS, Machunda R, Sapuli A, Pramanik S, Arun Kumar JV, Tiwari P, Mathews Mathuram GN, Bembeleza LB, Laiser JP, Luhwago WJ, Maduka TP, Mollel JO, Mollel NG, Mugizi AA, Mwamakula IL, Rweyemamu RE, Samweli UF, Simpito JI, Shirima KE, Anbalagan A, Arumugam SK, Dhanapal V, Gunasekaran K, Kashyap N, Kumar D, Pandey D, Pandey P, Panneerselvam A, Rai S, Rajendran P, Sekar S, Sivalingam O, Soni P, Soni P, Thiagarajan TC.   +39 more
europepmc   +1 more source

Steam-electric plant air and water quality control data. Summary report for the year ended December 31, 1976, based on FPC Form No. 67

, 1979

openalex   +2 more sources

Water resources data for North Dakota, water year 1974; Part 2, Water quality records [PDF]

, 1975
N Abercrombie
openalex   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Theoretical Study of Am(III) and Eu(III) Separation by a Bipyridyl Phosphate Ligand

ACS Omega
Xinyi Zhang, Lulu Ye, Weihao Chen, Xiaofei Zhang, Weiwei Chen, Miaogen Chen, Pinwen Huang   +6 more
doaj   +1 more source

fNIRS reproducibility varies with data quality, analysis pipelines, and researcher experience. [PDF]

Commun Biol
Yücel MA, Luke R, Mesquita RC, von Lühmann A, Mehler DMA, Lührs M, Gemignani J, Abdalmalak A, Albrecht F, de Almeida Ivo I, Artemenko C, Ashton K, Augustynowicz P, Bajracharya A, Bannier E, Barth B, Bayet L, Behrendt J, Khani HB, Borot L, Borrell JA, Brigadoi S, Brink K, Bulgarelli C, Caruyer E, Chen HC, Copeland C, Corouge I, Cutini S, Di Lorenzo R, Dresler T, Eggebrecht AT, Ehlis AC, Erdoğan SB, Evenblij D, Ferdous TR, Fracalossi V, Franzén E, Gallagher A, Gerloff C, Gervain J, Goldhamer N, Gossé LK, Guérin SMR, Guevara E, Hosseini SMH, Innes-Brown H, Int-Veen I, Jaffe-Dax S, Jégou N, Kawaguchi H, Kelsey C, Kent M, Kessler R, Kherbawy N, Klein F, Kochavi N, Kolisnyk M, Koren Y, Kroczek A, Kvist A, Lin CP, Löw A, Luan S, Mao D, Martins GG, Middell E, Montero-Hernandez S, Mutlu MC, Novi SL, Paquette N, Paranawithana I, Parmet Y, Peelle JE, Peng K, Peng T, Pereira J, Pinti P, Pollonini L, Jounghani AR, Reindl V, Ringels W, Schopp B, Schulte A, Schulte-Rüther M, Segel A, Ala TS, Shader MJ, Shavit H, Sherafati A, Soltanlou M, Sorger B, Speh E, Stubbs KD, Stute K, Sullivan EF, Tak S, Tipado Z, Tremblay J, Vahidi H, Van Eeckhoutte M, Vannasing P, Vergotte G, Vincent MA, Weiss E, Yang D, Yükselen G, Zapała D, Zemanek V.   +108 more
europepmc   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source